查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587275

膠原蛋白和 HA 基生醫材料市場：按類型、按應用分類 – 2025-2030 年全球預測

Collagen & HA-Based Biomaterials Market by Type (Corneal Shields, Facial Aesthetic Dermal Fillers, Urinary Incontinence), Application (Cosmetology, Food industry, Medicine) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年膠原蛋白和HA基生醫材料市場價值為71.1億美元，預計2024年將達到75.8億美元，複合年成長率為6.70%，到2030年將達到112億美元。

基於膠原蛋白和 HA（透明質酸）的生醫材料的範圍和定義涵蓋了它們在醫療和美容應用中的用途，因為它們具有生物相容性、生物分解性、組織工程功能、創傷治療和美容作用。這些生醫材料由於能夠模擬細胞外基質並有助於細胞增殖和組織再生，因此在醫療保健中至關重要。應用範圍廣泛，從真皮填充劑和抗衰老解決方案到整形外科手術和藥物傳輸系統。最終用途包括醫院、專科診所和研究機構，應用範圍從治療到美容。人口老化、對微創美容手術的需求不斷增加以及提高產品功效和安全性的生物技術進步是市場成長的主要因素。

主要市場統計
基準年[2023] 71.1億美元
預測年份 [2024] 75.8億美元
預測年份 [2030] 112.1億美元
複合年成長率（%） 6.70%

然而，高成本、嚴格的監管核准和過敏反應風險等限制可能會阻礙市場擴張。競爭格局中的另一個挑戰是，眾多參與者競相爭取市場佔有率，導致差異化變得困難。儘管如此，由於醫療保健意識的增強和可支配收入的增加，新興市場仍然存在快速成長的機會。公司可以透過創新滿足不同消費者需求的經濟高效的多功能生醫材料、遵守嚴格的品質標準以及透過策略夥伴關係關係擴大業務來利用這些機會。

充滿潛力的創新領域包括開發將膠原蛋白和透明質酸結合在一起並具有增強特性的混合材料、探索新的輸送機制以及利用 3D 列印實現個人化醫療解決方案。此外，對永續生產技術的重視可能會吸引具有環保意識的消費者和監管機構。基於膠原蛋白和透明質酸的生醫材料市場是一個充滿活力的市場，其特點是技術快速進步和消費者偏好不斷變化，這使得持續適應和創​​新對公司至關重要。對研發的策略性投資以及對監管環境和消費者需求的深入了解對於業務成長和保持競爭力至關重要。

市場動態：快速發展的膠原蛋白和透明質酸生醫材料市場的關鍵市場洞察

供應和需求的動態相互作用正在改變膠原蛋白和透明質酸基生醫材料市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 人口老化加劇，美容化妝品需求增加
    • 改善醫療基礎設施並發展再生醫學領域
    • 透過增加對生醫材料新興企業的投資來擴大產品範圍
  • 市場限制因素
    • 與複雜的製造流程相關的高成本
  • 市場機會
    • 積極的研究活動開發先進的透明質酸基聚合物
    • 3D列印技術在醫療保健應用中的出現
  • 市場挑戰
    • 與膠原蛋白和 HA 基生醫材料的再現性和免疫抗原性相關的挑戰

波特五力：駕馭膠原蛋白與玻尿酸生醫材料市場的策略工具

波特的五力框架是了解膠原蛋白和玻尿酸生醫材料市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解膠原蛋白和 HA 基生醫材料市場的外部影響

外部宏觀環境因素在塑造膠原蛋白和 HA 基生醫材料市場的性能動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解膠原蛋白和玻尿酸生醫材料市場的競爭格局

對膠原蛋白和透明質酸生醫材料市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質膠原蛋白和HA基生醫材料市場供應商的績效評估

FPNV定位矩陣是評估膠原蛋白和HA基生醫材料市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議膠原蛋白和透明質酸生醫材料市場的成功指明了道路

對於想要加強在全球市場的影響力的公司來說，對膠原蛋白和透明質酸生醫材料市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇，美容化妝品需求增加
      • 改善醫療基礎設施並發展再生醫學領域
      • 對生醫材料Start-Ups的投資增加，擴大產品範圍
    • 抑制因素
      • 生產流程複雜且高成本
    • 機會
      • 大力研究開發先進的玻尿酸基聚合物
      • 3D列印技術在醫療保健領域的出現
    • 任務
      • 與膠原蛋白和 HA 基生醫材料的再現性和免疫抗原性相關的挑戰
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章膠原蛋白和透明質酸基生醫材料市場：按類型

  • 角膜盾
  • 臉部美容真皮填充劑
  • 尿失禁
  • 傷口敷料

第7章膠原蛋白和透明質酸基生醫材料市場：依應用分類

  • 美麗
  • 食品工業
  • 藥品

第8章美洲膠原蛋白和透明質酸生醫材料市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區膠原蛋白和透明質酸生醫材料市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的膠原蛋白和玻尿酸生醫材料市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories.
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Becton, Dickinson and Company
  • BioCell Technology LLC
  • Boston Scientific Corporation
  • CaP Biomaterials, LLC
  • Collagen Solutions Ltd.
  • Coloplast A/S
  • Evonik Industries AG
  • Galderma Laboratories, LP
  • Integra LifeSciences Corporation
  • Matexcel
  • Promedon SA
  • Rousselot by Darling Ingredients International Holding BV
  • Viscofan Group
Product Code: MRR-521BAA36EA73

The Collagen & HA-Based Biomaterials Market was valued at USD 7.11 billion in 2023, expected to reach USD 7.58 billion in 2024, and is projected to grow at a CAGR of 6.70%, to USD 11.21 billion by 2030.

The scope and definition of collagen and HA-based (hyaluronic acid) biomaterials encompass their use in medical and cosmetic applications, attributed to their biocompatibility, biodegradability, and functionality in tissue engineering, wound healing, and aesthetic enhancements. These biomaterials are crucial in healthcare due to their ability to mimic the extracellular matrix, aiding cell proliferation and tissue regeneration. Applications are broad, ranging from dermal fillers and anti-aging solutions to orthopedic surgeries and drug delivery systems. The end-use scope includes hospitals, specialty clinics, and research institutes, reflecting a wide gamut of therapeutic and cosmetic utilizations. Market growth is strongly spurred by an aging population, increased demand for minimally invasive cosmetic procedures, and advancements in biotechnology that enhance product efficacy and safety.

KEY MARKET STATISTICS
Base Year [2023] USD 7.11 billion
Estimated Year [2024] USD 7.58 billion
Forecast Year [2030] USD 11.21 billion
CAGR (%) 6.70%

However, limitations include high costs, strict regulatory approvals, and the risk of allergic reactions, which can hinder market expansion. Challenging factors also encompass the competitive landscape with numerous players striving for market share, which can make differentiation challenging. Even so, burgeoning opportunities exist in emerging markets due to increased healthcare awareness and rising disposable incomes. Companies can capitalize on these opportunities by innovating cost-effective and versatile biomaterials that cater to diverse consumer needs, adhering to stringent quality standards, and expanding through strategic partnerships.

Innovation areas rife with potential include developing hybrid materials that combine collagen and HA for enhanced properties, exploring new delivery mechanisms, and leveraging 3D printing for personalized medicine solutions. Additionally, emphasis on sustainable production techniques could appeal to eco-conscious consumers and regulatory bodies alike. The collagen and HA-based biomaterials market is dynamic, characterized by rapid technological advancements and shifting consumer preferences, making it essential for companies to continually adapt and innovate. Structuring strategic investments in research and development, combined with a strong understanding of regulatory landscapes and consumer demands, is vital for driving business growth and maintaining a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Collagen & HA-Based Biomaterials Market

The Collagen & HA-Based Biomaterials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing aging population and demand for aesthetic cosmetic products
    • Improved healthcare infrastructure and growing field of regenerative medicines
    • Rising investments in biomaterial startups to expand their offerings
  • Market Restraints
    • High costs associated with complex and intricate production processes
  • Market Opportunities
    • Robust research activities to develop advanced HA-based polymers
    • Advent of 3D printing technology in healthcare applications
  • Market Challenges
    • Challenges associated with reproducibility and immunogenicity of collagen & HA-based biomaterials

Porter's Five Forces: A Strategic Tool for Navigating the Collagen & HA-Based Biomaterials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Collagen & HA-Based Biomaterials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Collagen & HA-Based Biomaterials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Collagen & HA-Based Biomaterials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Collagen & HA-Based Biomaterials Market

A detailed market share analysis in the Collagen & HA-Based Biomaterials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Collagen & HA-Based Biomaterials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Collagen & HA-Based Biomaterials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Collagen & HA-Based Biomaterials Market

A strategic analysis of the Collagen & HA-Based Biomaterials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Collagen & HA-Based Biomaterials Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories., AbbVie Inc., Bausch Health Companies Inc., Becton, Dickinson and Company, BioCell Technology LLC, Boston Scientific Corporation, CaP Biomaterials, LLC, Collagen Solutions Ltd., Coloplast A/S, Evonik Industries AG, Galderma Laboratories, L.P., Integra LifeSciences Corporation, Matexcel, Promedon S.A., Rousselot by Darling Ingredients International Holding B.V., and Viscofan Group.

Market Segmentation & Coverage

This research report categorizes the Collagen & HA-Based Biomaterials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Corneal Shields, Facial Aesthetic Dermal Fillers, Urinary Incontinence, and Wound Dressings.
  • Based on Application, market is studied across Cosmetology, Food industry, and Medicine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population and demand for aesthetic cosmetic products
      • 5.1.1.2. Improved healthcare infrastructure and growing field of regenerative medicines
      • 5.1.1.3. Rising investments in biomaterial startups to expand their offerings
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with complex and intricate production processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust research activities to develop advanced HA-based polymers
      • 5.1.3.2. Advent of 3D printing technology in healthcare applications
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges associated with reproducibility and immunogenicity of collagen & HA-based biomaterials
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Collagen & HA-Based Biomaterials Market, by Type

  • 6.1. Introduction
  • 6.2. Corneal Shields
  • 6.3. Facial Aesthetic Dermal Fillers
  • 6.4. Urinary Incontinence
  • 6.5. Wound Dressings

7. Collagen & HA-Based Biomaterials Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetology
  • 7.3. Food industry
  • 7.4. Medicine

8. Americas Collagen & HA-Based Biomaterials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Collagen & HA-Based Biomaterials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Collagen & HA-Based Biomaterials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories.
  • 2. AbbVie Inc.
  • 3. Bausch Health Companies Inc.
  • 4. Becton, Dickinson and Company
  • 5. BioCell Technology LLC
  • 6. Boston Scientific Corporation
  • 7. CaP Biomaterials, LLC
  • 8. Collagen Solutions Ltd.
  • 9. Coloplast A/S
  • 10. Evonik Industries AG
  • 11. Galderma Laboratories, L.P.
  • 12. Integra LifeSciences Corporation
  • 13. Matexcel
  • 14. Promedon S.A.
  • 15. Rousselot by Darling Ingredients International Holding B.V.
  • 16. Viscofan Group

LIST OF FIGURES

  • FIGURE 1. COLLAGEN & HA-BASED BIOMATERIALS MARKET RESEARCH PROCESS
  • FIGURE 2. COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. COLLAGEN & HA-BASED BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. COLLAGEN & HA-BASED BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLLAGEN & HA-BASED BIOMATERIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COLLAGEN & HA-BASED BIOMATERIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CORNEAL SHIELDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY FACIAL AESTHETIC DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COSMETOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. COLLAGEN & HA-BASED BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. COLLAGEN & HA-BASED BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2023